MILAN, Italy, October 14, 2026 — Apeloa Pharmaceutical has been named winner of the 2026 Service Excellence Award by a leading global pharmaceutical company, in recognition of its professional capabilities, delivery quality, and customer service. The award is the highest honor the company bestows on its global partners, recognizing outstanding performance in responsiveness, delivery quality, and collaboration efficiency.
The announcement came during a European trip led by Brian Zhu, Assistant President of Hengdian Group and Chairman & CEO of Apeloa Pharmaceutical, who headed a delegation to CPHI Milan 2026, the world's premier pharmaceutical ingredients exhibition. At the event, Apeloa engaged in in-depth exchanges with global pharmaceutical partners on industry trends, technological innovation, and deeper collaboration. Following the exhibition, Brian Zhu continued across Europe with the company's business development and scientific teams, visiting key partners on site and holding senior-level talks on expanding cooperation.
At the award ceremony, senior executives of the client company presented the trophy to Brian Zhu and commended the professionalism and dedication of the Apeloa team.
The award builds on a partnership forged during one of the industry's most challenging periods. The collaboration began several years ago with a key project that immediately faced the disruption of the COVID-19 pandemic: cross-border logistics were constrained, document exchange became difficult, and in-person travel was suspended—every step of project execution was tested as never before.
Faced with these obstacles, the Apeloa team and the client quickly came together as "one team." Working in close coordination, both sides pooled resources and flexibly adjusted plans to clear bottlenecks in logistics, supply chain, and delivery, ultimately completing the project on time and to specification. That success under pressure did more than deliver a project—it earned Apeloa the client's deep trust and respect, paving the way for broader and deeper collaboration. In the years since, more and more projects have been entrusted to Apeloa, and strategic mutual trust has been steadily reinforced.
The trust behind this award reflects Apeloa's long-standing commitment to a customer-centric philosophy. Throughout the partnership, the team has worked to understand the client's business in depth, identifying critical touchpoints and potential risks across the service chain, and building a systematic, full-cycle service assurance mechanism. Rather than merely reacting to issues, the team rapidly mobilizes cross-functional expertise to proactively resolve challenges and ensure quality at every stage—an approach the client has come to regard as both professional and genuinely caring.
The award is a strong endorsement of Apeloa's overall capabilities, reflecting the company's accumulated strengths in technology and management, as well as its global coordination capacity and international service standards.
The honor marks both a milestone and a new starting point. Apeloa will continue to upgrade its service system and technical capabilities, enhance international collaboration, and work alongside global partners—contributing Apeloa's expertise and Chinese strength to the cause of human health.
